Developing how the heart forms and brain works. How to analyze sarcasm computationally. Harnessing computers to develop campaign rhetoric across the spectrum. Halıcıoğlu Data Science Institute announced innovative undergraduate research scholarship projects…
Researchers from the University of Michigan relied on supercomputers at UC San Diego and elsewhere to help them develop detailed models to better understand how TB spreads throughout the lungs.
A new paper by UC San Diego researchers hypothesizes a possible link between cancer-causing viruses.
New preclinical data from University of California San Diego School of Medicine and Moores Cancer Center offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.
UC San Diego researchers have discovered an unexpected mechanism that allows bacteria to defend themselves against antibiotics, a finding that could lead to retooled drugs to treat infectious diseases.
New research reveals that foreign honey bees often account for more than 90 percent of pollinators observed visiting flowers in San Diego, a global biodiversity hotspot. The monopoly may strongly affect species that are foundational to the stability of the region’s plant-pollinator interactions.
UC San Diego will host its 9th annual Center for Circadian Biology Symposium Feb. 13-15, 2019. The three-day event, entitled “From Cells to Clinic,” will culminate with a talk from the winner of the 2017 Nobel Prize in Medicine Michael W. Young, who will speak about delayed phase sleep disorders.
University of California San Diego, in a collaborative agreement with Leica Microsystems, Inc., hosted a signing ceremony to inaugurate a new Leica Microsystems Center of Excellence on the School of Medicine campus.
UC San Diego researchers studying p53, the heralded cancer-fighting “guardian of the genome,” found that the human protein also plays a role in promoting tumors, in addition to suppressing them.
Using active genetics technology, biologists have developed the world’s first CRISPR/Cas9-based approach to control genetic inheritance in a mammal. The achievement in mice lays the groundwork for further advances based on this technology, including biomedical research on human disease.